SCIENION AG, a leading solution provider for ultra-low volume liquid handling applications, today announced that its new subsidiary Cellenion SASU started operations in Lyon, France back in May 2016 and has just launched its new website. Cellenion focuses on controlled cell dispensing technologies in the fields of bioprinting and single-cell dispensing. The young company was already awarded with the prestigious BIOVISION Catalyzer Project award in April 2016.
Berlin, Germany, and Toronto, Canada, MAY 24, 2016: SCIENION AG, a developer of a revolutionary new ultra-low volume liquid handling technology, is pleased to announce that it has entered into a strategic, joint development agreement with AXELA Inc. AXELA provides integrated technology platforms based on proprietary flow through arrays for molecular diagnostics. Available in both high throughput and sample to answer, point-of-use formats, they allow sensitive, multiplex detection of nucleic acids and proteins across broad clinical applications.
Berlin, Germany, and San Diego, USA, MAY 04, 2016: SCIENION AG, a leading provider of ultra-low volume precision liquid handling systems, and University of California San Diego, today announced that chemists at UC San Diego and automation experts at SCIENION have developed a new tool that allows scientists for the first time to see, at the scale of five billionths of a meter, “nanoscale” mixing processes occurring in liquids.
Berlin, Germany, and Kremsmünster, Austria, November 13, 2015: SCIENION AG, a leading provider of ultra-low volume precision liquid handling systems, and Greiner Bio-One, a leading manufacturer of synthetic materials for health services and a pioneer of new medical technology, today announced that they have entered into an agreement to co-develop advanced tests and integrated solutions for rapid and multiplexed diagnostics.
Berlin, Germany, and Fairfield, Australia, September 15, 2015: SCIENION AG, a leading provider of ultra-low volume precision liquid handling systems, and Axxin Pty Ltd., a leader in commercializing diagnostic instrument systems, today announced that they have partnered to collaborate on an instrument reader system for the analysis of multiplexed microarrays on lateral flow immunoassay strips.
Berlin, Germany, and Brisbane, Australia, July 24, 2015: SCIENION, a leading global provider of ultra-low volume precision liquid handling systems, and Australian biotech company Anteo Technologies today announced that they have partnered to co-develop protein microarray consumables using Anteo’s proprietary Mix&Go™ technology. Mix&Go activated surface consumables improve functionality and stability of biological molecules.
Newcastle-Upon-Tyne, England and Berlin, Germany, June 9, 2015: British medical device developer QuantuMDx (QMDx) and German life sciences company SCIENION have partnered to take QMDx’s highly multiplexed nanowire array to market. This biosensor is a component of QMDx’s flagship product Q-POC™, a handheld molecular diagnostic device that will provide results in 15 minutes for a few pounds at the patient’s side.
Monmouth Junction, NJ, USA, March 18, 2015: SCIENION US, Inc., a leading global provider of microarray services for custom assays, today announced that its entire portfolio of microarray services is now manufactured under ISO 13485 certification, an internationally recognized standard for quality management systems (QMS). The certification is accredited by TÜV SÜD America Inc.
Berlin, Germany, Belfast, Northern Ireland, and Boulder, CO, USA, October 8, 2014: SCIENION AG, The Institute for Global Food Security (IGFS) at Queen’s University Belfast and MBio Diagnostics today announced that IGFS are using SCIENION technology for the manufacturing of portable immunoassay cartridges.
Professor Chris Elliott’s group at IGFS is currently using sciFLEXARRAYER technology to produce arrays in cartridges for the multiplexed detection of marine toxins utilizing the MBio portable SnapEsi® assay platform.